Published in Proteomics Weekly, October 5th, 2009
"We have determined serum tryptase levels in 914 patients with haematological malignancies, including myeloproliferative disorders (n=156), myelodysplastic syndromes (MDS, n=241), acute myeloid leukaemia (AML,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly